Filter by
Date
Cancer type
Cancer stage
Biomarker
Method of analysis
Selected categories
October, 2024
Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment
Analysis of Circulating Tumor Cells Lab, Department of Chemistry, National and Kapodistrian University of Athens, Greece
October 2024
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer
Comprehensive Cancer Center, Medical University of Vienna, Austria
September, 2024
Low‑pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple‑negative breast cancer
Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Italy
August, 2024
Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations
ANGLE Europe Limited, Guildford, UK, University of Rochester, Rochester, US, and MD Anderson Cancer Center, Houston, US
August 2024
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland
July 2024
Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients
Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
1
23 ...
17